Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis

Weill Cornell Medical College, New York

Hunter Holmes McGuire VA Medical Center, Richmond

Liver Institute of Virginia, Newport News

University of Miami, Miami

University of Louisville, Louisville

Indiana University, Indianapolis

Henry Ford Health System, Detroit

Minnesota Gastroenterology, Saint Paul

Mayo Clinic, Rochester

University of Chicago Medical Center, Chicago

St. Louis University, St Louis

University of Texas Southwestern Medical Center, Dallas

Advanced Liver Therapies at St. Lukes Episcopal Hospital, Houston

University of Utah Health Science Center, Salt Lake City

Scripps Clinic, La Jolla

University of California at Davis, Sacramento

University of Washington Harborview Medical Center, Seattle

University Health Network, Toronto Western Hospital, Toronto

University of Birmingham, Birmingham

Royal Liverpool & Broadgreen University Hospital, Liverpool

Newcastle University, Newcastle upon Tyne

Oxford University Hospitals (John Radcliffe), Oxford

Royal Free Hospital, London

Imperial College London St Mary's Hospital, London